| 2026 |
| 03/09 | 9,602 | 9,899 | 9,602 | 9,870 | -1.89% | 1,516,900 | 5兆3593億 | -1.85% |
| 03/06 | 9,944 | 10,070 | 9,880 | 10,060 | -1.08% | 1,245,000 | 5兆4624億 | +0.33% |
| 03/05 | （5%ルール）野村證券（0.18%）野村アセットマネジメント（4.86%）ノムラインターナショナルピーエルシー(NOMURA IN…（0%） |
| 03/05 | 10,325 | 10,405 | 10,120 | 10,170 | +0.84% | 1,173,400 | 5兆5221億 | +1.81% |
| 03/04 | 9,940 | 10,120 | 9,895 | 10,085 | -0.49% | 1,326,700 | 5兆4760億 | +1.38% |
| 03/03 | 10,250 | 10,315 | 10,090 | 10,135 | -2.97% | 1,271,600 | 5兆5031億 | +2.14% |
| 03/02 | （IR情報）15:30 自己株式の取得状況に関するお知らせ |
| 03/02 | 10,525 | 10,625 | 10,375 | 10,445 | -2.47% | 1,303,200 | 5兆6715億 | +5.59% |
| 02/27 | 10,450 | 10,810 | 10,435 | 10,710 | +3.03% | 1,994,100 | 5兆8154億 | +8.85% |
| 02/26 | 10,260 | 10,465 | 10,260 | 10,395 | +0.05% | 1,597,300 | 5兆6443億 | +6.41% |
| 02/25 | 10,650 | 10,690 | 10,220 | 10,390 | -0.34% | 1,465,900 | 5兆6416億 | +6.99% |
| 02/24 | 10,570 | 10,585 | 10,265 | 10,425 | -1.84% | 1,674,900 | 5兆6606億 | +8.02% |
| 02/20 | 10,495 | 10,730 | 10,445 | 10,620 | +1.63% | 1,151,200 | 5兆7665億 | +10.69% |
| 02/19 | 10,215 | 10,545 | 10,215 | 10,450 | -1.55% | 1,098,800 | 5兆6742億 | +9.56% |
| 02/18 | 10,395 | 10,665 | 10,320 | 10,615 | +2.96% | 1,044,900 | 5兆7638億 | +11.9% |
| 02/17 | 10,600 | 10,650 | 10,270 | 10,310 | -3.73% | 1,160,900 | 5兆5982億 | +9.34% |
| 02/16 | 10,750 | 10,910 | 10,480 | 10,710 | +1.18% | 1,301,100 | 5兆8154億 | +14.18% |
| 02/13 | （IR情報）13:30 自己株式取得に係る事項の決定および自己株式の消却に関するお知らせ |
| 02/13 | （IR情報）13:30 投資単位の引下げに関する考え方および方針等について |
| 02/13 | （IR情報）13:30 2025年12月期決算短信〔IFRS〕(連結) |
| 02/13 | （IR情報）13:30 個別業績の前期実績との差異に関するお知らせ |
| 02/13 | 9,955 | 10,585 | 9,499 | 10,585 | +7.23% | 3,319,100 | 5兆7475億 | +13.57% |
| 02/12 | 9,956 | 9,956 | 9,813 | 9,871 | +0.14% | 1,061,800 | 5兆3598億 | +6.67% |
| 02/10 | 9,700 | 9,980 | 9,675 | 9,857 | +2.56% | 1,205,000 | 5兆3522億 | +6.99% |
| 02/09 | 9,700 | 9,842 | 9,558 | 9,611 | +2.86% | 1,474,000 | 5兆2186億 | +4.68% |
| 02/06 | 9,434 | 9,481 | 9,252 | 9,344 | -1.46% | 858,100 | 5兆736億 | +2.11% |
| 02/05 | 9,486 | 9,599 | 9,415 | 9,482 | +0.71% | 1,431,500 | 5兆1486億 | +3.81% |
| 02/04 | 9,423 | 9,511 | 9,330 | 9,415 | +0.44% | 1,140,300 | 5兆1122億 | +3.2% |
| 02/03 | 9,232 | 9,446 | 9,142 | 9,374 | +1.56% | 1,204,100 | 5兆899億 | +2.89% |
| 02/02 | 9,400 | 9,466 | 9,160 | 9,230 | -0.12% | 1,107,300 | 5兆117億 | +1.43% |
| 01/30 | 9,221 | 9,321 | 9,174 | 9,241 | +0.93% | 1,266,200 | 5兆177億 | +1.57% |
| 01/29 | 9,000 | 9,200 | 9,000 | 9,156 | +0.53% | 982,100 | 4兆9716億 | +0.71% |
| 01/28 | 9,053 | 9,152 | 8,995 | 9,108 | -0.39% | 1,158,800 | 4兆9455億 | +0.15% |
| 01/27 | 9,247 | 9,252 | 9,020 | 9,144 | -3.35% | 1,231,000 | 4兆9650億 | +0.48% |
| 01/26 | 9,376 | 9,594 | 9,252 | 9,461 | +1.27% | 1,544,700 | 5兆1372億 | +3.93% |
| 01/23 | 9,150 | 9,360 | 9,093 | 9,342 | +2.36% | 1,336,700 | 5兆726億 | +2.75% |
| 01/22 | 8,982 | 9,127 | 8,905 | 9,127 | +1.89% | 1,047,200 | 4兆9558億 | +0.41% |
| 01/21 | 8,925 | 9,177 | 8,897 | 8,958 | +0.04% | 1,089,200 | 4兆8640億 | -1.53% |
| 01/20 | 8,900 | 8,981 | 8,801 | 8,954 | +0.91% | 866,200 | 4兆8619億 | -1.72% |
| 01/19 | 8,910 | 9,000 | 8,794 | 8,873 | -1.58% | 649,000 | 4兆8179億 | -2.76% |
| 01/16 | 9,032 | 9,079 | 8,947 | 9,015 | -2.07% | 656,000 | 4兆8950億 | -1.36% |
| 01/15 | 9,174 | 9,273 | 9,135 | 9,206 | +0.52% | 754,300 | 4兆9987億 | +0.66% |
| 01/14 | 9,133 | 9,314 | 9,128 | 9,158 | -0.4% | 999,500 | 4兆9726億 | +0.15% |
| 01/13 | 9,209 | 9,345 | 9,130 | 9,195 | +1.16% | 1,102,200 | 4兆9927億 | +0.48% |
| 01/09 | 9,113 | 9,200 | 9,010 | 9,090 | -1.25% | 1,135,900 | 4兆9357億 | -0.6% |
| 01/08 | 9,060 | 9,249 | 9,015 | 9,205 | +3.07% | 1,152,900 | 4兆9982億 | +0.73% |
| 01/07 | 8,875 | 9,026 | 8,848 | 8,931 | +0.87% | 1,255,700 | 4兆8494億 | -2.04% |
| 01/06 | 8,896 | 8,918 | 8,671 | 8,854 | -2.15% | 1,467,000 | 4兆8076億 | -2.85% |
| 01/05 | 8,924 | 9,089 | 8,890 | 9,049 | +1.98% | 1,151,800 | 4兆9135億 | -0.7% |
| 2025 |
| 12/30 | 8,924 | 8,958 | 8,868 | 8,873 | -0.42% | 762,900 | 4兆8179億 | -2.63% |
| 12/29 | 9,096 | 9,096 | 8,910 | 8,910 | -3.14% | 960,300 | 4兆8380億 | -2.13% |
| 12/26 | 9,161 | 9,242 | 9,111 | 9,199 | +0.97% | 974,500 | 4兆9949億 | +1.2% |
| 12/25 | 9,189 | 9,200 | 9,100 | 9,111 | +0.1% | 590,700 | 4兆9471億 | +0.61% |
| 12/24 | 9,194 | 9,273 | 9,102 | 9,102 | -0.86% | 664,800 | 4兆9422億 | +0.89% |
| 12/23 | 9,111 | 9,247 | 8,932 | 9,181 | +1.09% | 751,500 | 4兆9851億 | +2.12% |
| 12/22 | 9,286 | 9,299 | 9,069 | 9,082 | -1.52% | 788,200 | 4兆9314億 | +1.37% |
| 12/19 | 9,250 | 9,377 | 9,215 | 9,222 | -0.3% | 1,494,400 | 5兆74億 | +3.26% |
| 12/18 | 9,270 | 9,357 | 9,219 | 9,250 | +0.23% | 869,100 | 5兆226億 | +4.05% |
| 12/17 | 9,225 | 9,231 | 9,033 | 9,229 | +0.53% | 789,100 | 5兆112億 | +4.22% |
| 12/16 | 9,360 | 9,364 | 9,173 | 9,180 | -1.23% | 961,800 | 4兆9846億 | +4.15% |
| 12/15 | 9,462 | 9,575 | 9,269 | 9,294 | -0.19% | 876,800 | 5兆465億 | +5.93% |
| 12/12 | 9,430 | 9,462 | 9,300 | 9,312 | +0.13% | 1,212,300 | 5兆563億 | +6.58% |
| 12/11 | 9,449 | 9,449 | 9,241 | 9,300 | -0.16% | 918,900 | 5兆497億 | +6.84% |
| 12/10 | 9,150 | 9,330 | 9,130 | 9,315 | +1.03% | 948,800 | 5兆579億 | +7.43% |
| 12/09 | 9,160 | 9,247 | 9,055 | 9,220 | +0.44% | 911,900 | 5兆63億 | +6.69% |
| 12/08 | 9,220 | 9,262 | 9,134 | 9,180 | +0.21% | 1,163,800 | 4兆9846億 | +6.64% |
| 12/05 | 9,189 | 9,241 | 9,083 | 9,161 | -1.84% | 1,093,000 | 4兆9743億 | +6.87% |
| 12/04 | 9,300 | 9,379 | 9,100 | 9,333 | +3.2% | 1,977,500 | 5兆677億 | +9.41% |
| 12/03 | 8,810 | 9,064 | 8,801 | 9,044 | +1.45% | 1,163,500 | 4兆9107億 | +6.58% |
| 12/02 | （5%ルール）野村證券（0.09%）野村アセットマネジメント（4.82%）ノムラインターナショナルピーエルシー(NOMURA IN…（0.05%） |
| 12/02 | 8,718 | 8,915 | 8,708 | 8,915 | +2.64% | 1,306,900 | 4兆8407億 | +5.4% |
| 12/01 | 8,770 | 8,854 | 8,632 | 8,686 | -1.81% | 949,400 | 4兆7164億 | +3% |
| 11/28 | 8,794 | 8,846 | 8,714 | 8,846 | +0.06% | 894,700 | 4兆8032億 | +5.08% |
| 11/27 | 8,980 | 9,106 | 8,829 | 8,841 | -2.06% | 882,300 | 4兆8005億 | +5.33% |
| 11/26 | 8,900 | 9,270 | 8,799 | 9,027 | +4.24% | 2,520,800 | 4兆9015億 | +7.86% |
| 11/26 | （IR情報）8:55 世界初のAPRIL抗体「VOYXACT(シベプレンリマブ)」が成人のIgA腎症治療薬として米国FDAより迅速承認を取得 |
| 11/25 | 8,659 | 8,709 | 8,545 | 8,660 | +1.09% | 1,251,500 | 4兆7022億 | +3.86% |
| 11/21 | 8,316 | 8,576 | 8,316 | 8,567 | +2.82% | 1,733,700 | 4兆6517億 | +2.99% |
| 11/20 | 8,303 | 8,474 | 8,270 | 8,332 | +0.75% | 1,098,300 | 4兆5241億 | +0.36% |
| 11/19 | 8,335 | 8,361 | 8,226 | 8,270 | -0.45% | 993,000 | 4兆4905億 | -0.23% |
| 11/18 | 8,314 | 8,456 | 8,303 | 8,307 | -1.18% | 815,900 | 4兆5106億 | +0.4% |
| 11/17 | 8,350 | 8,427 | 8,271 | 8,406 | +0.48% | 847,600 | 4兆5643億 | +1.69% |
| 11/14 | 8,213 | 8,403 | 8,150 | 8,366 | +2.05% | 1,127,900 | 4兆5426億 | +1.21% |
| 11/13 | 8,406 | 8,482 | 8,181 | 8,198 | -2.31% | 995,000 | 4兆4514億 | -0.85% |
| 11/12 | 8,330 | 8,392 | 8,171 | 8,392 | +2.35% | 1,503,600 | 4兆5567億 | +1.39% |
| 11/11 | 8,173 | 8,257 | 8,083 | 8,199 | +0.18% | 1,271,600 | 4兆4519億 | -0.97% |
| 11/10 | 8,364 | 8,381 | 8,170 | 8,184 | -2.22% | 901,700 | 4兆4438億 | -1.11% |
| 11/10 | （IR情報）8:30 「シベプレンリマブ」IgA腎症を対象としたフェーズ3試験結果を米国腎臓学会(ASN)で発表 |
| 11/07 | 8,511 | 8,550 | 8,250 | 8,370 | -1.66% | 793,100 | 4兆5448億 | +1.12% |
| 11/06 | 8,280 | 8,511 | 8,257 | 8,511 | +0.87% | 1,010,800 | 4兆6213億 | +2.88% |
| 11/05 | 8,629 | 8,708 | 8,310 | 8,438 | -1.87% | 1,554,800 | 4兆5817億 | +2.32% |
| 11/04 | 8,292 | 8,608 | 8,280 | 8,599 | +2.69% | 1,927,700 | 4兆6691億 | +4.62% |
| 10/31 | （IR情報）13:30 2025年12月期第3四半期決算短信〔IFRS〕(連結) |
| 10/31 | 8,234 | 8,449 | 8,090 | 8,374 | +1.1% | 1,627,700 | 4兆5469億 | +2.3% |
| 10/30 | 8,121 | 8,317 | 8,070 | 8,283 | +2.17% | 1,214,200 | 4兆4975億 | +1.37% |
| 10/29 | 8,234 | 8,276 | 8,018 | 8,107 | -1.41% | 863,800 | 4兆4020億 | -0.7% |
| 10/28 | 8,350 | 8,350 | 8,190 | 8,223 | -1.63% | 802,500 | 4兆4649億 | +0.75% |
| 10/27 | 8,397 | 8,430 | 8,338 | 8,359 | +0.89% | 724,500 | 4兆5388億 | +2.46% |
| 10/24 | 8,366 | 8,397 | 8,246 | 8,285 | -0.37% | 700,000 | 4兆4986億 | +1.64% |
| 10/23 | 8,280 | 8,356 | 8,214 | 8,316 | +1.12% | 861,200 | 4兆5154億 | +2.1% |
| 10/22 | 8,233 | 8,275 | 8,180 | 8,224 | -0.05% | 738,000 | 4兆4655億 | +0.88% |
| 10/21 | 8,269 | 8,280 | 8,199 | 8,228 | -0.34% | 763,700 | 4兆4677億 | +0.8% |
| 10/20 | 8,320 | 8,373 | 8,236 | 8,256 | +1.3% | 790,800 | 4兆4829億 | +1.05% |
| 10/17 | 8,176 | 8,189 | 8,083 | 8,150 | -0.32% | 659,000 | 4兆4253億 | -0.27% |
| 10/16 | 8,092 | 8,185 | 7,993 | 8,176 | +2.14% | 1,013,200 | 4兆4394億 | -0.13% |
| 10/15 | 7,949 | 8,005 | 7,891 | 8,005 | +1.33% | 1,154,100 | 4兆3466億 | -2.37% |
| 10/14 | 7,807 | 7,955 | 7,756 | 7,900 | -2.55% | 1,334,800 | 4兆2896億 | -3.76% |
| 10/10 | 8,400 | 8,404 | 8,070 | 8,107 | -3.61% | 1,651,300 | 4兆4020億 | -1.36% |
| 10/09 | 8,394 | 8,521 | 8,383 | 8,411 | +0.14% | 1,067,100 | 4兆5670億 | +2.37% |
| 10/08 | 8,540 | 8,567 | 8,365 | 8,399 | -0.49% | 1,030,100 | 4兆5605億 | +2.41% |
| 10/07 | （5%ルール）野村證券（0.07%）ノムラインターナショナルピーエルシー(NOMURA IN…（0.42%）野村アセットマネジメント（4.73%） |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
